These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8844874)

  • 1. Crystallization and preliminary X-ray diffraction studies of human procathepsin L.
    Coulombe R; Li Y; Takebe S; Ménard R; Mason P; Mort JS; Cygler M
    Proteins; 1996 Jul; 25(3):398-400. PubMed ID: 8844874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and crystallization of recombinant human cathepsin L.
    Nomura T; Fujishima A; Fujisawa Y
    Biochem Biophys Res Commun; 1996 Nov; 228(3):792-6. PubMed ID: 8941355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of human procathepsin K.
    LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
    Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
    Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
    J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocatalytic processing of recombinant human procathepsin L. Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in vitro.
    Ménard R; Carmona E; Takebe S; Dufour E; Plouffe C; Mason P; Mort JS
    J Biol Chem; 1998 Feb; 273(8):4478-84. PubMed ID: 9468501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of wild-type human procathepsin K.
    Sivaraman J; Lalumière M; Ménard R; Cygler M
    Protein Sci; 1999 Feb; 8(2):283-90. PubMed ID: 10048321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides.
    Chowdhury SF; Sivaraman J; Wang J; Devanathan G; Lachance P; Qi H; Ménard R; Lefebvre J; Konishi Y; Cygler M; Sulea T; Purisima EO
    J Med Chem; 2002 Nov; 45(24):5321-9. PubMed ID: 12431059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of rat procathepsin B.
    Sivaraman J; Coloumbe R; Magny MC; Mason P; Mort JS; Cygler M
    Acta Crystallogr D Biol Crystallogr; 1996 Jul; 52(Pt 4):874-5. PubMed ID: 15299656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex.
    Linnevers CJ; McGrath ME; Armstrong R; Mistry FR; Barnes MG; Klaus JL; Palmer JT; Katz BA; Brömme D
    Protein Sci; 1997 Apr; 6(4):919-21. PubMed ID: 9098904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary X-ray analysis of Streptococcus pneumoniae hyaluronate lyase.
    Jedrzejas MJ; Chantalat L; Mewbourne RB
    J Struct Biol; 1998 Jan; 121(1):73-5. PubMed ID: 9573623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unfolding/refolding step helps in the crystallization of a poorly soluble protein.
    Kaulmann G; Palm GJ; Schilling K; Hilgenfeld R; Wiederanders B
    Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1243-5. PubMed ID: 12832773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.
    Guillaume-Rousselet N; Jean D; Frade R
    Biochem J; 2002 Oct; 367(Pt 1):219-27. PubMed ID: 12241546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-based structure in the proregion of procathepsin L is the recognition site for mannose phosphorylation.
    Cuozzo JW; Tao K; Wu QL; Young W; Sahagian GG
    J Biol Chem; 1995 Jun; 270(26):15611-9. PubMed ID: 7797559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli.
    Kopitar G; Dolinar M; Strukelj B; Pungercar J; Turk V
    Eur J Biochem; 1996 Mar; 236(2):558-62. PubMed ID: 8612629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level expression and crystallization of recombinant human cathepsin S.
    Brömme D; McGrath ME
    Protein Sci; 1996 Apr; 5(4):789-91. PubMed ID: 8845771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, crystallization and preliminary X-ray diffraction analysis of the yeast phosphorelay protein YPD1.
    Xu Q; Nguyen V; West AH
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):291-3. PubMed ID: 10089428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitor.
    Ho JD; Meltser Y; Buggy JJ; Palmer JT; Elrod KC; Chan H; Mortara KD; Somoza JR
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2187-90. PubMed ID: 12454497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray crystallographic studies of recombinant human leukotriene A4 hydrolase complexed with bestatin.
    Tsuge H; Ago H; Aoki M; Furuno M; Noma M; Miyano M; Minami M; Izumi T; Shimizu T
    J Mol Biol; 1994 May; 238(5):854-6. PubMed ID: 8182755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized folding and activation of recombinant procathepsin L and S produced in Escherichia coli.
    Kramer G; Paul A; Kreusch A; Schüler S; Wiederanders B; Schilling K
    Protein Expr Purif; 2007 Jul; 54(1):147-56. PubMed ID: 17391985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.